The role of a poison control center in identifying and limiting an outbreak of foodborne botulism.
Many poison control centers partner with public health agencies to handle weekend and after-hours consultations and emergencies. This event describes the effective use of poison control center capabilities in identifying and limiting an outbreak of foodborne botulism. On September 8, 2006, the poison control center received a call regarding a man aged 77 years admitted to a hospital neurology service with dysarthria, dysphagia, and weakness. The poison control center was contacted regarding a concern for botulism. Further information revealed that the patient's wife and a friend had similar symptoms and had eaten together on the previous night. All three sought treatment at different hospitals. The poison control center successfully located the other two patients and provided information regarding the treatment of botulism. In addition, the poison control center notified the on-call local public health official and the CDC for the release of botulinum antitoxin. Public health officials were informed of our concerns for a foodborne outbreak given the common meal. Their investigation determined that the source of botulism was carrot juice.
Brown
Jennifer
J
Georgia Poison Center, Education Department, CDC, Atlanta, USA.
Sutter
Mark E
ME
Algren
D Adam
DA
Thomas
Jerry D
JD
Ragone
Sean
S
Schier
Joshua G
JG
Geller
Robert J
RJ
D000368:Aged; D001628:Beverages / Q000382:microbiology; D001904:Botulinum Antitoxin / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000302:isolation & purification; D001906:Botulism / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D002487:Centers for Disease Control and Prevention, U.S.; D018552:Daucus carota / Q000382:microbiology*; D004196:Disease Outbreaks / Q000517:prevention & control; D005260:Female; D005506:Food Contamination; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D011039:Poison Control Centers / Q000458:organization & administration*; D014481:United States
D001904:Botulinum Antitoxin; D007155:Immunologic Factors; D019274:Botulinum Toxins, Type A